0000224/2025 Framework Agreement With A Single Company, Which Sets The Conditions For The Supply Of Successive Tract By Unit Price Of The Exclusive Medicine Called Voxzogo (Active Principle Vosoritide®), Bound For The Pharmacy Service Of The Regional University Hospital Of Malaga Health Center Of The Provincial Purchas Offers Cca.: +6.6Fetj88

Name: 0000224/2025 Framework Agreement With A Single Company, Which Sets The Conditions For The Supply Of Successive Tract By Unit Price Of The Exclusive Medicine Called Voxzogo (Active Principle Vosoritide®), Bound For The Pharmacy Service Of The Regional University Hospital Of Malaga Health Center Of The Provincial Purchas Offers Cca.: +6.6Fetj88
Start: 2025-07-12
End: 2025-07-18
Location: Servicio Andaluz de Salud

Servicio Andaluz de Salud Spain has Released a tender for 0000224/2025 Framework Agreement With A Single Company, Which Sets The Conditions For The Supply Of Successive Tract By Unit Price Of The Exclusive Medicine Called Voxzogo (Active Principle Vosoritide®), Bound For The Pharmacy Service Of The Regional University Hospital Of Malaga Health Center Of The Provincial Purchas Offers Cca.: +6.6Fetj88 in Pharmaceuticals. The tender was released on Jul 11, 2025.

Country - Spain

Summary - 0000224/2025 Framework Agreement With A Single Company, Which Sets The Conditions For The Supply Of Successive Tract By Unit Price Of The Exclusive Medicine Called Voxzogo (Active Principle Vosoritide®), Bound For The Pharmacy Service Of The Regional University Hospital Of Malaga Health Center Of The Provincial Purchas Offers Cca.: +6.6Fetj88

Deadline - login to view

GT reference number - 113173198

Product classification - Pharmaceutical products

Organization Details:

Address - Spain

Contact details - 565656565

Tender notice no. - 76454545

GT Ref Id - 113173198

Document Type - Tender Notices

Notice Details and Documents:

Description - Description: Framework Agreement with a single company, which sets the conditions for the supply of successive tract by unit price of the exclusive drug called Voxzogo (active principle Vosoritide®), destined for the pharmacy service of the Regional University Hospital of Malaga Health Center of the Provincial Purchasing Central of Malaga, belonging to the Andalusian Health Service, through negotiated procedure without advertising and electronic presentation of offerslocal title:: 0000224/2025 ACUERDO MARCO CON UNA ÚNICA EMPRESA, POR EL QUE SE FIJAN LAS CONDICIONES PARA EL SUMINISTRO DE TRACTO SUCESIVO POR PRECIO UNITARIO DEL MEDICAMENTO EXCLUSIVO DENOMINADO VOXZOGO (PRINCIPIO ACTIVO VOSOR

Gt Ref Id - 113173198

Deadline - Jul 18, 2025